Innovative therapies are often based on new treatment algorithms and thus require different processes than conventional therapies.

When new therapies are introduced, neither the provider nor the healthcare provider can foresee exactly whether and how the healthcare provider's human and financial resource requirements will change due to the application of new therapies.

A process cost analysis helps to ensure planning security.

A process cost analysis shows providers and users which medical, nursing, technical and administrative staff are involved in which activities in the treatment process and to what extent. The need for human, material and financial resources can thus be quantified over the entire treatment process and also compared with other therapies.

"Medically comparable therapies do not always cause comparable costs. Transparent therapy costs are the prerequisite for an efficient use of resources."

Time is a limited resource in healthcare, so we use a software-based approach (Ibexx©). To minimise the time needed by the healthcare provider, we first create a process model based on standard operating procedures (SOPs), publications and our experience. The model is then validated and adjusted with the people involved.

The costs are then calculated by our team using anonymised controlling data.

Our software Ibexx© enables a graphical representation and the use of standardised names of individual services and processes to enable a comparison of different treatments and/or settings (e.g. university hospital vs. acute hospital).

Thus, the software saves time in validating and adapting the model with involved persons.